Johnson & Johnson (JNJ)
Data as of September 4, 2026 · Drug Manufacturers - General
Stockbruh grade: Strong 5/5 metrics rated Sunny
What does Johnson & Johnson do?
Johnson & Johnson is a global healthcare company that develops and sells a wide range of products to take care of you from head to toe! From JOHNSON'S baby care products to LISTERINE oral care, NEUTROGENA skin health, and BAND-AID adhesive bandages, they've got you covered. Headquartered in New Brunswick, New Jersey, Johnson & Johnson is here to keep you healthy and happy! 🌟💪🏼😊.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ☀️ Strong | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ☀️ Strong | Revenue & earnings trend |
| Earnings | ☀️ Strong | EPS vs analyst expectations |
| Cash & Debt | ☀️ Strong | Balance sheet strength |
| Price | $275.21 | Market Cap | — |
| Exchange | New York Stock Exchange | | |
Plain-English Analysis
What's it worth?
Based on 5-year performance trends, Johnson & Johnson has historically delivered strong returns. Sign up free for full valuation analysis including P/E, DCF estimates, and Stockbruh's plain-English take on whether this stock looks cheap or expensive right now.
How the business works
Johnson & Johnson is a global healthcare company that develops and sells a wide range of products to take care of you from head to toe! From JOHNSON'S baby care products to LISTERINE oral care, NEUTROGENA skin health, and BAND-AID adhesive bandages, they've got you covered. Headquartered in New Brunswick, New Jersey, Johnson & Johnson is here to keep you healthy and happy! 🌟💪🏼😊. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Revenue and earnings are trending upward — Johnson & Johnson appears to be growing. Sign up free for the full growth analysis including year-over-year comparisons and R&D investment data.
What's ahead?
Recent earnings have been strong, meeting or beating analyst expectations. Sign up free for earnings history, EPS trends, and what analysts are forecasting next.